Omnicell ROA 2012-2026 | OMCL
Current and historical return on assets (ROA) values for Omnicell (OMCL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Omnicell ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-06-30 | $0.04B | $1.98B | 1.92% |
| 2026-03-31 | $0.02B | $2.02B | 0.99% |
| 2025-12-31 | $0.00B | $2.06B | 0.10% |
| 2025-09-30 | $0.02B | $2.09B | 0.96% |
| 2025-06-30 | $0.02B | $2.18B | 1.10% |
| 2025-03-31 | $0.02B | $2.22B | 0.99% |
| 2024-12-31 | $0.01B | $2.25B | 0.58% |
| 2024-09-30 | $-0.02B | $2.28B | -0.75% |
| 2024-06-30 | $-0.02B | $2.26B | -0.89% |
| 2024-03-31 | $-0.02B | $2.23B | -0.94% |
| 2023-12-31 | $-0.02B | $2.22B | -0.90% |
| 2023-09-30 | $-0.03B | $2.22B | -1.53% |
| 2023-06-30 | $-0.02B | $2.21B | -1.04% |
| 2023-03-31 | $-0.02B | $2.19B | -0.78% |
| 2022-12-31 | $0.01B | $2.16B | 0.28% |
| 2022-09-30 | $0.05B | $2.14B | 2.24% |
| 2022-06-30 | $0.06B | $2.11B | 2.84% |
| 2022-03-31 | $0.07B | $2.07B | 3.43% |
| 2021-12-31 | $0.08B | $2.01B | 3.83% |
| 2021-09-30 | $0.08B | $1.93B | 4.09% |
| 2021-06-30 | $0.06B | $1.85B | 3.19% |
| 2021-03-31 | $0.04B | $1.66B | 2.10% |
| 2020-12-31 | $0.03B | $1.50B | 2.13% |
| 2020-09-30 | $0.04B | $1.35B | 2.81% |
| 2020-06-30 | $0.05B | $1.24B | 3.97% |
| 2020-03-31 | $0.07B | $1.23B | 5.62% |
| 2019-12-31 | $0.06B | $1.22B | 5.02% |
| 2019-09-30 | $0.05B | $1.18B | 4.60% |
| 2019-06-30 | $0.05B | $1.13B | 4.26% |
| 2019-03-31 | $0.04B | $1.08B | 3.60% |
| 2018-12-31 | $0.04B | $1.05B | 3.71% |
| 2018-09-30 | $0.06B | $1.03B | 5.32% |
| 2018-06-30 | $0.05B | $1.00B | 4.89% |
| 2018-03-31 | $0.04B | $0.97B | 4.52% |
| 2017-12-31 | $0.03B | $0.94B | 3.30% |
| 2017-09-30 | $0.01B | $0.92B | 0.98% |
| 2017-06-30 | $0.00B | $0.92B | 0.33% |
| 2017-03-31 | $0.00B | $0.92B | 0.00% |
| 2016-12-31 | $0.01B | $0.93B | 1.08% |
| 2016-09-30 | $0.01B | $0.84B | 1.08% |
| 2016-06-30 | $0.02B | $0.75B | 2.00% |
| 2016-03-31 | $0.03B | $0.67B | 3.73% |
| 2015-12-31 | $0.03B | $0.58B | 5.33% |
| 2015-09-30 | $0.03B | $0.58B | 5.54% |
| 2015-06-30 | $0.03B | $0.57B | 5.44% |
| 2015-03-31 | $0.03B | $0.55B | 5.42% |
| 2014-12-31 | $0.03B | $0.54B | 5.57% |
| 2014-09-30 | $0.03B | $0.52B | 5.37% |
| 2014-06-30 | $0.03B | $0.51B | 5.67% |
| 2014-03-31 | $0.03B | $0.50B | 5.45% |
| 2013-12-31 | $0.02B | $0.48B | 4.98% |
| 2013-09-30 | $0.02B | $0.47B | 4.90% |
| 2013-06-30 | $0.02B | $0.45B | 4.91% |
| 2013-03-31 | $0.02B | $0.43B | 3.94% |
| 2012-12-31 | $0.02B | $0.41B | 3.90% |
| 2012-09-30 | $0.01B | $0.39B | 3.58% |
| 2012-06-30 | $0.01B | $0.38B | 2.66% |
| 2012-03-31 | $0.01B | $0.36B | 3.32% |
| 2011-12-31 | $0.01B | $0.35B | 3.11% |
| 2011-09-30 | $0.01B | $0.35B | 2.29% |
| 2011-06-30 | $0.01B | $0.34B | 1.74% |
| 2011-03-31 | $0.01B | $0.34B | 1.47% |
| 2010-12-31 | $0.01B | $0.34B | 1.48% |
| 2010-09-30 | $0.01B | $0.33B | 1.51% |
| 2010-06-30 | $0.01B | $0.33B | 1.53% |
| 2010-03-31 | $0.00B | $0.32B | 1.24% |
| 2009-12-31 | $0.00B | $0.32B | 0.32% |
| 2009-09-30 | $0.00B | $0.31B | 0.96% |
| 2009-06-30 | $0.01B | $0.31B | 1.63% |
| 2009-03-31 | $0.01B | $0.30B | 2.35% |
| 2008-12-31 | $0.01B | $0.30B | 4.35% |
| 2008-09-30 | $0.02B | $0.30B | 7.91% |
| 2008-06-30 | $0.03B | $0.30B | 9.22% |
| 2008-03-31 | $0.04B | $0.30B | 14.23% |
| 2007-12-31 | $0.04B | $0.27B | 16.24% |
| 2007-09-30 | $0.03B | $0.22B | 14.90% |
| 2007-06-30 | $0.03B | $0.18B | 15.89% |
| 2007-03-31 | $0.01B | $0.14B | 9.04% |
| 2006-12-31 | $0.01B | $0.13B | 7.63% |
| 2006-09-30 | $0.01B | $0.12B | 6.82% |
| 2006-06-30 | $0.01B | $0.11B | 5.53% |
| 2006-03-31 | $0.00B | $0.10B | 3.94% |
| 2005-12-31 | $0.00B | $0.10B | -3.05% |
| 2005-09-30 | $0.00B | $0.10B | -2.04% |
| 2005-06-30 | $0.00B | $0.10B | 0.00% |
| 2005-03-31 | $0.00B | $0.10B | 2.06% |
| 2004-12-31 | $0.01B | $0.10B | 10.42% |
| 2004-09-30 | $0.01B | $0.09B | 10.84% |
| 2004-06-30 | $0.01B | $0.09B | 10.56% |
| 2004-03-31 | $0.01B | $0.08B | 10.29% |
| 2003-12-31 | $0.01B | $0.07B | 8.54% |
| 2003-09-30 | $0.00B | $0.07B | -2.99% |
| 2003-06-30 | $-0.01B | $0.07B | -10.49% |
| 2003-03-31 | $-0.01B | $0.07B | -8.86% |
| 2002-12-31 | $0.00B | $0.07B | -5.76% |
| 2002-09-30 | $0.00B | $0.07B | 2.87% |
| 2002-06-30 | $0.01B | $0.07B | 7.17% |
| 2002-03-31 | $0.00B | $0.06B | 3.11% |
| 2001-12-31 | $0.00B | $0.06B | -3.39% |
| 2001-06-30 | $-0.01B | $0.02B | -42.55% |
| 2001-03-31 | $-0.01B | $0.01B | -119.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.524B | $1.185B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |